NATURAL HEALTH TRENDS CORP (NHTC) Fundamental Analysis & Valuation

NASDAQ:NHTC • US63888P4063

Current stock price

2.77 USD
-0.01 (-0.36%)
Last:

This NHTC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. NHTC Profitability Analysis

1.1 Basic Checks

  • In the past year NHTC has reported negative net income.
  • In the past year NHTC has reported a negative cash flow from operations.
  • Of the past 5 years NHTC 4 years were profitable.
  • NHTC had negative operating cash flow in 4 of the past 5 years.
NHTC Yearly Net Income VS EBIT VS OCF VS FCFNHTC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

1.2 Ratios

  • NHTC's Return On Assets of -2.30% is in line compared to the rest of the industry. NHTC outperforms 43.24% of its industry peers.
  • NHTC has a Return On Equity of -3.76%. This is comparable to the rest of the industry: NHTC outperforms 56.76% of its industry peers.
Industry RankSector Rank
ROA -2.3%
ROE -3.76%
ROIC N/A
ROA(3y)-0.15%
ROA(5y)0.21%
ROE(3y)-0.22%
ROE(5y)0.36%
ROIC(3y)N/A
ROIC(5y)N/A
NHTC Yearly ROA, ROE, ROICNHTC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • With a decent Gross Margin value of 73.54%, NHTC is doing good in the industry, outperforming 78.38% of the companies in the same industry.
  • NHTC's Gross Margin has been stable in the last couple of years.
  • NHTC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.25%
NHTC Yearly Profit, Operating, Gross MarginsNHTC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NHTC Health Analysis

2.1 Basic Checks

  • NHTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NHTC has about the same amount of shares outstanding.
  • NHTC has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NHTC Yearly Shares OutstandingNHTC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
NHTC Yearly Total Debt VS Total AssetsNHTC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • NHTC has an Altman-Z score of 1.14. This is a bad value and indicates that NHTC is not financially healthy and even has some risk of bankruptcy.
  • NHTC has a Altman-Z score (1.14) which is comparable to the rest of the industry.
  • There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACCN/A
WACC9.08%
NHTC Yearly LT Debt VS Equity VS FCFNHTC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 2.50 indicates that NHTC has no problem at all paying its short term obligations.
  • NHTC has a Current ratio of 2.50. This is in the better half of the industry: NHTC outperforms 67.57% of its industry peers.
  • A Quick Ratio of 2.35 indicates that NHTC has no problem at all paying its short term obligations.
  • The Quick ratio of NHTC (2.35) is better than 75.68% of its industry peers.
Industry RankSector Rank
Current Ratio 2.5
Quick Ratio 2.35
NHTC Yearly Current Assets VS Current LiabilitesNHTC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. NHTC Growth Analysis

3.1 Past

  • The earnings per share for NHTC have decreased strongly by -233.33% in the last year.
  • The Revenue has decreased by -7.42% in the past year.
  • NHTC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.52% yearly.
EPS 1Y (TTM)-233.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-350%
Revenue 1Y (TTM)-7.42%
Revenue growth 3Y-6.78%
Revenue growth 5Y-8.52%
Sales Q2Q%-10.14%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHTC Yearly Revenue VS EstimatesNHTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
NHTC Yearly EPS VS EstimatesNHTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 0.05 -0.05

More info and screens

Find the best growth stocksShow best growing peers

0

4. NHTC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NHTC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NHTC Price Earnings VS Forward Price EarningsNHTC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NHTC Per share dataNHTC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. NHTC Dividend Analysis

5.1 Amount

  • NHTC has a Yearly Dividend Yield of 14.18%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.76, NHTC pays a better dividend. On top of this NHTC pays more dividend than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, NHTC pays a better dividend.
Industry RankSector Rank
Dividend Yield 14.18%

5.2 History

  • The dividend of NHTC decreases each year by -0.04%.
  • NHTC has paid a dividend for at least 10 years, which is a reliable track record.
  • NHTC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.04%
Div Incr Years0
Div Non Decr Years10
NHTC Yearly Dividends per shareNHTC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • The earnings of NHTC are negative and hence is the payout ratio. NHTC will probably not be able to sustain this dividend level.
DP-1044.22%
EPS Next 2YN/A
EPS Next 3YN/A
NHTC Yearly Income VS Free CF VS DividendNHTC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

More info and screens

Find the best dividend stocksShow peers with best dividend

NHTC Fundamentals: All Metrics, Ratios and Statistics

NATURAL HEALTH TRENDS CORP

NASDAQ:NHTC (3/30/2026, 8:20:44 PM)

2.77

-0.01 (-0.36%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-04
Earnings (Next)04-28
Inst Owners13.16%
Inst Owner Change-18.11%
Ins Owners20.94%
Ins Owner Change0%
Market Cap23.77M
Revenue(TTM)39.78M
Net Income(TTM)-882.00K
Analysts0
Price TargetN/A
Short Float %0.76%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield 14.18%
Yearly Dividend0.8
Dividend Growth(5Y)-0.04%
DP-1044.22%
Div Incr Years0
Div Non Decr Years10
Ex-Date02-17
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB 1.01
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.71
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS4.64
BVpS2.73
TBVpS2.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.3%
ROE -3.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.54%
FCFM N/A
ROA(3y)-0.15%
ROA(5y)0.21%
ROE(3y)-0.22%
ROE(5y)0.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.25%
F-Score3
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.39%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.5
Quick Ratio 2.35
Altman-Z 1.14
F-Score3
WACC9.08%
ROIC/WACCN/A
Cap/Depr(3y)44.65%
Cap/Depr(5y)56.12%
Cap/Sales(3y)0.14%
Cap/Sales(5y)0.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-233.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-350%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.42%
Revenue growth 3Y-6.78%
Revenue growth 5Y-8.52%
Sales Q2Q%-10.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-39.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.11%
OCF growth 3YN/A
OCF growth 5YN/A

NATURAL HEALTH TRENDS CORP / NHTC Fundamental Analysis FAQ

What is the fundamental rating for NHTC stock?

ChartMill assigns a fundamental rating of 3 / 10 to NHTC.


What is the valuation status for NHTC stock?

ChartMill assigns a valuation rating of 0 / 10 to NATURAL HEALTH TRENDS CORP (NHTC). This can be considered as Overvalued.


What is the profitability of NHTC stock?

NATURAL HEALTH TRENDS CORP (NHTC) has a profitability rating of 2 / 10.


Is the dividend of NATURAL HEALTH TRENDS CORP sustainable?

The dividend rating of NATURAL HEALTH TRENDS CORP (NHTC) is 6 / 10 and the dividend payout ratio is -1044.22%.